Appropriate therapeutic drug monitoring of vancomycin improves outcomes of patients with bacterial infection in ICU.

IF 1.6 4区医学 Q3 PHARMACOLOGY & PHARMACY

European journal of hospital pharmacy : science and practice Pub Date : 2024-07-30 DOI:10.1136/ejhpharm-2024-004299

Xiaohua Zhou, Hongjian Ji

引用次数: 0

查看原文本刊更多论文

对万古霉素进行适当的治疗药物监测可改善重症监护病房细菌感染患者的预后。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European journal of hospital pharmacy : science and practice PHARMACOLOGY & PHARMACY-

CiteScore

3.40

自引率

5.90%

发文量

104

审稿时长

6-12 weeks

期刊介绍： European Journal of Hospital Pharmacy (EJHP) offers a high quality, peer-reviewed platform for the publication of practical and innovative research which aims to strengthen the profile and professional status of hospital pharmacists. EJHP is committed to being the leading journal on all aspects of hospital pharmacy, thereby advancing the science, practice and profession of hospital pharmacy. The journal aims to become a major source for education and inspiration to improve practice and the standard of patient care in hospitals and related institutions worldwide. EJHP is the only official journal of the European Association of Hospital Pharmacists.